Concepedia

Tanja Lahaye

TL

Statistics

Publications

14

Citations

2.1K

H-Index

13

Active since

2001

Affiliations

Heidelberg University(Current)

Novartis (Germany)

University Hospital Heidelberg

University of Mannheim

University Medical Center Hamburg-Eppendorf

Tanja Lahaye is an author at Heidelberg University specializing in hematology, medicine, and chronic myeloid leukemia therapy.

Publications per year

2001–2007

14

Publications

14

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

Andreas Hochhaus, Sebastian Kreil, A. Corbin et al. · Leukemia · 2002 · 905 citations

, , +11

Response and resistance in 300 patients with BCR‐ABL–positive leukemias treated with imatinib in a single center

Tanja Lahaye, Birte Riehm, Ute Berger et al. · Cancer · 2005 · 229 citations

, , +13

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α

Kirsten Merx, M. C. Muller, Sebastian Kreil et al. · Leukemia · 2002 · 172 citations

, , +15

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia

Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann et al. · Blood · 2007 · 168 citations · Full text

, , +7

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

Andreas Burchert, Stefan Wölfl, Manuel Schmidt et al. · Blood · 2002 · 136 citations · Full text

, , +10

1–5 of 14